High-Performance Liquid Chromatography (HPLC) Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

High-Performance Liquid Chromatography Market Analysis

The Global High-Performance Liquid Chromatography (HPLC) Market size is expected to grow from USD 4.79 billion in 2023 to USD 5.96 billion by 2028, at a CAGR of 4.45% during the forecast period (2023-2028).

The healthcare system has witnessed enormous challenges as a result of the COVID-19 pandemic. All outpatient treatments were postponed or restricted during the COVID-19 pandemic to reduce the risk of viral transmission as most chronic therapies were regarded as non-urgent. However, research and development focusing on the SARS-CoV-2 virus and the identification of potential drug candidates have been on the rise during the pandemic. HPLC is an important technique used in drug formulation laboratories for the identification and analysis of specific components in a drug mixture. An article titled “A stability indicating RP-HPLC method for determination of the COVID-19 drug molnupiravir applied using nanoformulations in permeability studies” published in the Journal of Pharmaceutical and Biomedical Analysis in May 2022 studied the permeability quantitation of Molnupiravir in nanoformulations. The study established that the reversed-phase HPLC method is more applicable for the routine analysis of Molnupiravir compared to the Liquid Chromatography - Mass Spectrometry / Mass Spectrometry methods. The rise in the applications of the HPLC systems in the COVID-19 study is propelling the growth of the studied market in the forecast period.

The recent advancements in the HPLC studies are adding to the growth of the market. According to an article published in the journal of Current Opinion in Chemical Engineering in June 2021 titled “Recent advances in modeling and control of liquid chromatography”, HPLC is highly versatile, used for fast analysis and high yield separation at both preparative and process scale and is the most common separation method in the production of pharmaceutical and biopharmaceutical products. The article indicated that the combination of computational and experimental work can help the adoption of more complex models and reduce the simulation time and will facilitate faster screening of multidimensional operation spaces for parameter estimation and optimization. The advances made in the HPLC sector will likely add to the market growth in the forecast period.

Several key market players have also been interested in the development and manufacturing of innovative HPLC-based systems for various laboratory functions, including diagnostics. For instance, in June 2021, Trivitron Healthcare launched HPLC-based diagnostic solutions, the HbA1c analyzers used for monitoring diabetes, thalassemia, and hemoglobin variants. The fully automated NANO H5 analyzer can process five samples at a time. The NANO H110 is a compact, automated HPLC analyzer that has a dual test mode for HbA1c test and Hb Variant detection, with a high sample loading capacity of 110 samples at a time. Such innovations are expected to propel market growth in the study period. However, the lack of skilled personnel and the high cost of the HPLC systems are likely to hinder the market growth in the forecast period.

High-Performance Liquid Chromatography Market Trends

This section covers the major market trends shaping the High-Performance Liquid Chromatography Market according to our research experts:

Consumables Segment is Expected to Hold a Major Market Share in the High-Performance Liquid Chromatography (HPLC) Market

High-Performance Liquid Chromatography Industry Segmentation

As per the scope of the report, High-performance liquid chromatography (HPLC) is used to separate, identify and quantify the components in a given mixture. HPLC is one of the types of column chromatography, in which the components are separated using solubility. The high-performance liquid chromatography (HPLC) market is segmented by product type (instruments, consumables, and accessories), application (protein expression, cloning, and others), end-user (pharma biopharmaceutical companies, contract research organizations, and academic institutions), and geography(North America, Europe, Asia-Pacific, Middle East and Africa and South America). The Market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers values in (in USD million) for the above segments.